159 related articles for article (PubMed ID: 23844739)
1. Conditional cardiac overexpression of S100A6 attenuates myocyte hypertrophy and apoptosis following myocardial infarction.
Tsoporis JT; Izhar S; Desjardins JF; Leong-Poi H; Parker TG
Curr Pharm Des; 2014; 20(12):1941-9. PubMed ID: 23844739
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Overexpression of S100A6 Attenuates Cardiomyocyte Apoptosis and Reduces Infarct Size After Myocardial Ischemia-Reperfusion.
Mofid A; Newman NS; Lee PJ; Abbasi C; Matkar PN; Rudenko D; Kuliszewski MA; Chen HH; Afrasiabi K; Tsoporis JN; Gramolini AO; Connelly KA; Parker TG; Leong-Poi H
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28174168
[TBL] [Abstract][Full Text] [Related]
3. Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-alpha.
Tsoporis JN; Izhar S; Parker TG
J Biol Chem; 2008 Oct; 283(44):30174-83. PubMed ID: 18753141
[TBL] [Abstract][Full Text] [Related]
4. S100A6 is a negative regulator of the induction of cardiac genes by trophic stimuli in cultured rat myocytes.
Tsoporis JN; Marks A; Haddad A; O'Hanlon D; Jolly S; Parker TG
Exp Cell Res; 2005 Feb; 303(2):471-81. PubMed ID: 15652358
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of norepinephrine-induced cardiac hypertrophy in s100beta transgenic mice.
Tsoporis JN; Marks A; Kahn HJ; Butany JW; Liu PP; O'Hanlon D; Parker TG
J Clin Invest; 1998 Oct; 102(8):1609-16. PubMed ID: 9788975
[TBL] [Abstract][Full Text] [Related]
6. S100B expression modulates left ventricular remodeling after myocardial infarction in mice.
Tsoporis JN; Marks A; Haddad A; Dawood F; Liu PP; Parker TG
Circulation; 2005 Feb; 111(5):598-606. PubMed ID: 15699280
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice.
Xiang FL; Lu X; Hammoud L; Zhu P; Chidiac P; Robbins J; Feng Q
Circulation; 2009 Sep; 120(12):1065-74, 9 p following 1074. PubMed ID: 19738140
[TBL] [Abstract][Full Text] [Related]
8. Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype.
Yue P; Long CS; Austin R; Chang KC; Simpson PC; Massie BM
J Mol Cell Cardiol; 1998 Aug; 30(8):1615-30. PubMed ID: 9737947
[TBL] [Abstract][Full Text] [Related]
9. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
10. Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
Li HL; Zhuo ML; Wang D; Wang AB; Cai H; Sun LH; Yang Q; Huang Y; Wei YS; Liu PP; Liu DP; Liang CC
Circulation; 2007 Apr; 115(14):1885-94. PubMed ID: 17389268
[TBL] [Abstract][Full Text] [Related]
11. Cardiac transgenesis with the tetracycline transactivator changes myocardial function and gene expression.
McCloskey DT; Turnbull L; Swigart PM; Zambon AC; Turcato S; Joho S; Grossman W; Conklin BR; Simpson PC; Baker AJ
Physiol Genomics; 2005 Jun; 22(1):118-26. PubMed ID: 15797971
[TBL] [Abstract][Full Text] [Related]
12. S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction.
Tsoporis JN; Izhar S; Leong-Poi H; Desjardins JF; Huttunen HJ; Parker TG
Circ Res; 2010 Jan; 106(1):93-101. PubMed ID: 19910580
[TBL] [Abstract][Full Text] [Related]
13. Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice.
Yang LL; Gros R; Kabir MG; Sadi A; Gotlieb AI; Husain M; Stewart DJ
Circulation; 2004 Jan; 109(2):255-61. PubMed ID: 14718401
[TBL] [Abstract][Full Text] [Related]
14. Cardiac-specific expression of the tetracycline transactivator confers increased heart function and survival following ischemia reperfusion injury.
Elsherif L; Wang X; Grachoff M; Wolska BM; Geenen DL; O'Bryan JP
PLoS One; 2012; 7(1):e30129. PubMed ID: 22272284
[TBL] [Abstract][Full Text] [Related]
15. Altered cardiac hormone and contractile protein messenger RNA levels following left ventricular myocardial infarction in the rat: an in situ hybridization histochemical study.
Young RL; Gundlach AL; Louis WJ
Cardiovasc Res; 1998 Jan; 37(1):187-201. PubMed ID: 9539873
[TBL] [Abstract][Full Text] [Related]
16. Induction of S100b in myocardium: an intrinsic inhibitor of cardiac hypertrophy.
Parker TG; Marks A; Tsoporis JN
Can J Appl Physiol; 1998 Aug; 23(4):377-89. PubMed ID: 9677434
[TBL] [Abstract][Full Text] [Related]
17. Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction.
Qian JY; Harding P; Liu Y; Shesely E; Yang XP; LaPointe MC
Hypertension; 2008 Feb; 51(2):560-6. PubMed ID: 18180401
[TBL] [Abstract][Full Text] [Related]
18. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of TIMP-1 in embryonic stem cells attenuates adverse cardiac remodeling following myocardial infarction.
Glass C; Singla DK
Cell Transplant; 2012; 21(9):1931-44. PubMed ID: 22449760
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Tbx20 in Adult Cardiomyocytes Promotes Proliferation and Improves Cardiac Function After Myocardial Infarction.
Xiang FL; Guo M; Yutzey KE
Circulation; 2016 Mar; 133(11):1081-92. PubMed ID: 26841808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
